Aquiderm

Created in 2014, Aquiderm is a technology transfer unit hosted within the Inserm U1035 unit and administratively attached to ADERA.
Specialized in skin biology, Aquiderm focuses on pathological skin models such as psoriasis, vitiligo, and atopic dermatitis, as well as healthy tissues. It facilitates technology transfer to local, national and international industry partners.

Aquiderm offers its expertise and technical know-how to private cosmetic companies such as Nuxe, Clarins, and Bioderma, as well as startups. In these cases, it works on healthy skin models to scientifically support product claims related to anti-aging care, sun protection, skin-lightening, and more.

Using both cellular and tissue-based models, Aquiderm performs primary cultures (keratinocytes, melanocytes, fibroblasts, endothelial cells, PBMCs, etc.), works with established cell lines, and develops 3D skin models such as reconstructed human epidermis (pigmented or not) and skin explants.

Project managers Jérôme Rambert and Muriel Cario oversee projects from start to finish and conduct both proteomic and transcriptomic analyses. The unit also boasts a well-equipped histology platform capable of processing and analyzing all types of tissue samples.

Based at the University of Bordeaux, Aquiderm benefits from a dynamic scientific environment, collaborating with other technology transfer units such as CELLOMET and Aquitaine Microbiologie, as well as TBMCore platforms like Vect’UB and CellOxia.

Aquiderm is certified as a Research Tax Credit (Crédit Impôt Recherche) expert, allowing its clients to benefit from tax incentives on services provided by the unit.
 
Contact:
Jérôme Rambert
aquiderm@gmail.com

Learn more:
Aquiderm

Cellomet

Created in 2015, CELLOMET is a technology transfer unit and a branch of ADERA SAS, a company specialized in research and development.

Emerging from the U1211 MRGM laboratory, CELLOMET focuses on energy metabolism studies for both industrial and academic sectors.

CELLOMET provides services to the pharmaceutical and cosmetics industries across Europe and the United States, and to a lesser extent, collaborates with French academic laboratories.

Composed of metabolism and biochemistry experts, CELLOMET operates a proprietary technological platform dedicated to metabolic pathway analysis (Seahorse, Oroboros, Biolog) and pathway remodeling (proteomics, metabolomics, bioinformatics). The unit supports its clients in designing and executing R&D projects in areas such as bioenergetics, mitochondrial physiology, respiratory chain modulation, oxidative stress, and metabolic reprogramming.

CELLOMET’s team offers tailored experimental design and expertise in interpreting results related to mitochondrial genetics, metabolo-proteomics, and REDOX signaling. The unit is led by founder Rodrigue Rossignol and manager Nivea Dias Amoedo, supported by a team of three additional members.

CELLOMET maintains strong ties with its parent laboratory U1211, where several students carry out parts of their research projects. For some, CELLOMET has served as a springboard into the world of start-ups and the industrial sector. The unit also contributes to training, notably through the University of Bordeaux’s “Industry Master” programs, and participates in European courses on entrepreneurship in biotechnology.

CELLOMET is accredited as a Research Tax Credit (Crédit Impôt Recherche) expert, allowing clients to benefit from tax deductions on services provided by the unit.

Contact:
Nivea Dias Amoedo
nivea.amoedo@cellomet.com

Learn more:
Cellomet

Created in late 2010, Aquitaine Microbiologie is a technology transfer unit of the University of Bordeaux, specialized in microbiology services and research and development projects. Serving as an interface between fundamental research and the industrial world, the unit carries out activities complementary to the expertise of the MFP laboratory, which hosts it.

Aquitaine Microbiologie provides public and private institutions, as well as companies in the pharmaceutical, cosmetic, veterinary, agri-food, and biotechnology sectors, with access to high-performance, state-of-the-art equipment.

In human medicine, for example, and in collaboration with several clinical departments of the Bordeaux University Hospital (CHU), the unit conducts evaluations of new therapeutic molecules, medical devices, and rapid diagnostic tests for infections.

Three permanent staff members carry out the unit’s services, and many interns, Master’s students, and clinicians from the Bordeaux University Hospital also receive training there.

Over the years, the unit has expanded its range of services. To date, it provides services to around thirty clients per year, both in France and internationally.

From 2017 to 2020, the Aqui-Litt project - a pioneering “One Health” initiative led by the unit and conducted in collaboration with clinicians from the CHU de Bordeaux -enabled the analysis of samples from the Aquitaine coastline (from La Rochelle to Bayonne). The goal was to map marine microorganisms, identify reservoirs of antimicrobial-resistant strains, and better understand transmission and dissemination routes between humans, animals, and the environment. This study allowed for a comparative analysis of results obtained simultaneously from marine samples, livestock from the Aquitaine coast, and extracts from hospital and primary care records.

This environmental health project continues today. It has already given rise to a new three-year “One Health” initiative called NOVA-Litt (Nouvelle Aquitaine Littoral), which will consolidate the data gathered during the Aqui-Litt project.

Contact :
Dr Fatima M'ZALI
Responsable 
fatima.mzali@u-bordeaux.fr

Learn more:
Aquitaine Microbiologie